Print
Share
RSS
Donate
News
If you suspect that you have COVID-19, it is essential that you contact your healthcare provider to confirm the diagnosis and to determine if you are at high-risk of requiring hospitalization. These treatments can reduce the severity of COVID-19 in…
The SADS Foundation just released a COVID-19 Vaccine statement that recommends that all individuals with SADS conditions receive a vaccination. Michael J. Ackerman, MD, PhD, director of the Long QT Syndrome Clinic and professor of medicine,…
Three new drugs have been added and one removed from the Possible Risk of TdP category for the QTdrugs list. Two drugs used for prostate cancer (Bicalutamide and Relugolix) and an antibiotic (Linezolid) have been added to the Possible Risk category.…
Today, Tuesday April 6th, AZCERT, the makers of CredibleMeds and MedSafety Scan, will participate in "Arizona Gives Day," a statewide online charitable giving event to inspire people to give generously to nonprofit organizations who make our state…
Two drugs newly marketed in the US, Ponesimod for treatment of multiple sclerosis and Voclosporin for treatment of lupus nephritis, have been added to the QTdrugs list in the Possible Risk of TdP category. They will also be added to the list of…
Text for citing the use of the QTdrugs List or the CredibleMeds.org website:
Woosley RL, Heise CW, Gallo T, Woosley RD, Lambson J. and Romero KA, www.CredibleMeds.org, QTdrugs List, [Accession Date], AZCERT, 1457 E. Desert Garden Dr., Tucson, AZ 85718
Copyright: The CredibleMeds® website is intended for personal and professional use only. Its content is protected by U.S. Copyright. Unauthorized use for commercial purposes is prohibited.